Global mRNA Vaccine Market Insights, Forecast to 2025

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The global mRNA Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the mRNA Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of mRNA Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of mRNA Vaccine in these regions.
This research report categorizes the global mRNA Vaccine market by top players/brands, region, type and end user. This report also studies the global mRNA Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Market size by Product
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Market size by End User
Infectious Disease
Cancer
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global mRNA Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of mRNA Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global mRNA Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of mRNA Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of mRNA Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of mRNA Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 mRNA Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global mRNA Vaccine Market Size Growth Rate by Product
1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
1.4.3 Individualized Cancer Treatment MRNA Vaccine
1.4.4 Infectious Disease Treatment MRNA Vaccine
1.4.5 Infection Prevention MRNA Vaccine
1.5 Market by End User
1.5.1 Global mRNA Vaccine Market Size Growth Rate by End User
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global mRNA Vaccine Market Size
2.1.1 Global mRNA Vaccine Revenue 2014-2025
2.1.2 Global mRNA Vaccine Sales 2014-2025
2.2 mRNA Vaccine Growth Rate by Regions
2.2.1 Global mRNA Vaccine Sales by Regions
2.2.2 Global mRNA Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 mRNA Vaccine Sales by Manufacturers
3.1.1 mRNA Vaccine Sales by Manufacturers
3.1.2 mRNA Vaccine Sales Market Share by Manufacturers
3.1.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 mRNA Vaccine Revenue by Manufacturers
3.2.1 mRNA Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 mRNA Vaccine Price by Manufacturers
3.4 mRNA Vaccine Manufacturing Base Distribution, Product Types
3.4.1 mRNA Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers mRNA Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into mRNA Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global mRNA Vaccine Sales by Product
4.2 Global mRNA Vaccine Revenue by Product
4.3 mRNA Vaccine Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global mRNA Vaccine Breakdown Data by End User

6 North America
6.1 North America mRNA Vaccine by Countries
6.1.1 North America mRNA Vaccine Sales by Countries
6.1.2 North America mRNA Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America mRNA Vaccine by Product
6.3 North America mRNA Vaccine by End User

7 Europe
7.1 Europe mRNA Vaccine by Countries
7.1.1 Europe mRNA Vaccine Sales by Countries
7.1.2 Europe mRNA Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe mRNA Vaccine by Product
7.3 Europe mRNA Vaccine by End User

8 Asia Pacific
8.1 Asia Pacific mRNA Vaccine by Countries
8.1.1 Asia Pacific mRNA Vaccine Sales by Countries
8.1.2 Asia Pacific mRNA Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific mRNA Vaccine by Product
8.3 Asia Pacific mRNA Vaccine by End User

9 Central & South America
9.1 Central & South America mRNA Vaccine by Countries
9.1.1 Central & South America mRNA Vaccine Sales by Countries
9.1.2 Central & South America mRNA Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America mRNA Vaccine by Product
9.3 Central & South America mRNA Vaccine by End User

10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccine by Countries
10.1.1 Middle East and Africa mRNA Vaccine Sales by Countries
10.1.2 Middle East and Africa mRNA Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa mRNA Vaccine by Product
10.3 Middle East and Africa mRNA Vaccine by End User

11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Company Business Overview
11.1.3 Moderna Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 Company Business Overview
11.2.3 CureVac mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CureVac mRNA Vaccine Products Offered
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Company Business Overview
11.3.3 Translate Bio mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Translate Bio mRNA Vaccine Products Offered
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 Company Business Overview
11.4.3 BioNTech mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 BioNTech mRNA Vaccine Products Offered
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Sangamo Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sangamo Therapeutics mRNA Vaccine Products Offered
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Company Business Overview
11.6.3 Argos Therapeutics mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Argos Therapeutics mRNA Vaccine Products Offered
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 Company Business Overview
11.7.3 In-Cell-Art mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 In-Cell-Art mRNA Vaccine Products Offered
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 Company Business Overview
11.8.3 eTheRNA mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 eTheRNA mRNA Vaccine Products Offered
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Company Business Overview
11.9.3 Ethris mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ethris mRNA Vaccine Products Offered
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Company Business Overview
11.10.3 Tiba Biotechnology mRNA Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Tiba Biotechnology mRNA Vaccine Products Offered
11.10.5 Tiba Biotechnology Recent Development

12 Future Forecast
12.1 mRNA Vaccine Market Forecast by Regions
12.1.1 Global mRNA Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global mRNA Vaccine Revenue Forecast by Regions 2019-2025
12.2 mRNA Vaccine Market Forecast by Product
12.2.1 Global mRNA Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global mRNA Vaccine Revenue Forecast by Product 2019-2025
12.3 mRNA Vaccine Market Forecast by End User
12.4 North America mRNA Vaccine Forecast
12.5 Europe mRNA Vaccine Forecast
12.6 Asia Pacific mRNA Vaccine Forecast
12.7 Central & South America mRNA Vaccine Forecast
12.8 Middle East and Africa mRNA Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 mRNA Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure mRNA Vaccine Product Picture
Table mRNA Vaccine Market Segments
Table Key Manufacturers mRNA Vaccine Covered
Table Global mRNA Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global mRNA Vaccine Sales Market Share by Product 2014-2025
Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Standardization Of Cancer Treatment MRNA Vaccine
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Individualized Cancer Treatment MRNA Vaccine
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Table Major Manufacturers of Infectious Disease Treatment MRNA Vaccine
Figure Infection Prevention MRNA Vaccine Product Picture
Table Major Manufacturers of Infection Prevention MRNA Vaccine
Table Global mRNA Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Infectious Disease
Figure Cancer
Figure Other
Figure mRNA Vaccine Report Years Considered
Figure Global mRNA Vaccine Market Size 2014-2025 (Million US$)
Figure Global mRNA Vaccine Sales 2014-2025 (K Doses)
Table Global mRNA Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global mRNA Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global mRNA Vaccine Sales Market Share by Regions 2014-2019
Figure Global mRNA Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global mRNA Vaccine Sales Market Share by Regions
Table Global mRNA Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global mRNA Vaccine Revenue Market Share by Regions 2014-2019
Figure Global mRNA Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global mRNA Vaccine Revenue Market Share by Regions
Table Global mRNA Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global mRNA Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global mRNA Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table mRNA Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table mRNA Vaccine Revenue Share by Manufacturers (2014-2019)
Figure mRNA Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers mRNA Vaccine Price (2014-2019) (USD/Dose)
Table mRNA Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers mRNA Vaccine Product Type
Table Date of International Manufacturers Enter into mRNA Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Global mRNA Vaccine Sales Share by Product (2014-2019)
Figure Global mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure Global mRNA Vaccine Sales Market Share by Product in 2018
Table Global mRNA Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global mRNA Vaccine Revenue Share by Product (2014-2019)
Figure Global mRNA Vaccine Revenue Market Share by Product (2014-2019)
Figure Global mRNA Vaccine Revenue Market Share by Product in 2018
Table mRNA Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Global mRNA Vaccine Sales Share by End User (2014-2019)
Figure Global Sales mRNA Vaccine Market Share by End User (2014-2019)
Figure Global Sales mRNA Vaccine Market Share by End User in 2018
Figure North America mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America mRNA Vaccine Sales Market Share by Countries
Table North America mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America mRNA Vaccine Revenue Market Share by Countries
Figure United States mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States mRNA Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table North America mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America mRNA Vaccine Market Share by Product
Table North America mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table North America mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America mRNA Vaccine Market Share by End User
Figure Europe mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe mRNA Vaccine Sales Market Share by Countries
Table Europe mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe mRNA Vaccine Revenue Market Share by Countries
Figure Germany mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe mRNA Vaccine Market Share by Product
Table Europe mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe mRNA Vaccine Market Share by End User
Figure Asia Pacific mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Sales Market Share by Countries
Table Asia Pacific mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Revenue Market Share by Countries
Figure China mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Market Share by Product
Table Asia Pacific mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific mRNA Vaccine Market Share by End User
Figure Central & South America mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Sales Market Share by Countries
Table Central & South America mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Revenue Market Share by Countries
Figure Brazil mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Market Share by Product
Table Central & South America mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America mRNA Vaccine Market Share by End User
Figure Middle East and Africa mRNA Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa mRNA Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa mRNA Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa mRNA Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Sales Market Share by Countries
Table Middle East and Africa mRNA Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa mRNA Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Revenue Market Share by Countries
Figure GCC Countries mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa mRNA Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa mRNA Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa mRNA Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa mRNA Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Market Share by Product
Table Middle East and Africa mRNA Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa mRNA Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa mRNA Vaccine Market Share by End User
Table Moderna Therapeutics Company Details
Table Moderna Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Moderna Therapeutics Recent Development

Table CureVac Company Details
Table CureVac mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CureVac Recent Development

Table Translate Bio Company Details
Table Translate Bio mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Translate Bio Recent Development

Table BioNTech Company Details
Table BioNTech mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table BioNTech Recent Development

Table Sangamo Therapeutics Company Details
Table Sangamo Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sangamo Therapeutics Recent Development

Table Argos Therapeutics Company Details
Table Argos Therapeutics mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Argos Therapeutics Recent Development

Table In-Cell-Art Company Details
Table In-Cell-Art mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table In-Cell-Art Recent Development

Table eTheRNA Company Details
Table eTheRNA mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table eTheRNA Recent Development

Table Ethris Company Details
Table Ethris mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Ethris Recent Development

Table Tiba Biotechnology Company Details
Table Tiba Biotechnology mRNA Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Tiba Biotechnology Recent Development

Table Global mRNA Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global mRNA Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global mRNA Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global mRNA Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global mRNA Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global mRNA Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global mRNA Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global mRNA Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global mRNA Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global mRNA Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa mRNA Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa mRNA Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table mRNA Vaccine Value Chain
Table mRNA Vaccine Customers List
Table mRNA Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type